Erdmann, F., Kaatsch, P., Grabow, D. & Spix, C. German Childhood Cancer Registry — Annual Report 2019 (1980–2018). Institute of Medical Biostatistics, Epidemiology and Informatics (IMBEI) at the University Medical Center of the Johannes Gutenberg University Mainz (2020).

Steliarova-Foucher, E. et al. International incidence of childhood cancer, 2001–10: a population-based registry study. Lancet Oncol. 18, 719–731 (2017).

Article  PubMed  PubMed Central  Google Scholar 

Lam, C. G., Howard, S. C., Bouffet, E. & Pritchard-Jones, K. Science and health for all children with cancer. Science 363, 1182–1186 (2019).

Article  CAS  PubMed  Google Scholar 

Suh, E. et al. Late mortality and chronic health conditions in long-term survivors of early-adolescent and young adult cancers: a retrospective cohort analysis from the Childhood Cancer Survivor Study. Lancet Oncol. 21, 421–435 (2020).

Article  PubMed  PubMed Central  Google Scholar 

Minino, A. M. & Smith, B. L. Deaths: preliminary data for 2000. Natl Vital. Stat. Rep. 49, 1–40 (2001).

CAS  PubMed  Google Scholar 

Zhang, J. et al. Germline mutations in predisposition genes in pediatric cancer. N. Engl. J. Med. 373, 2336–2346 (2015). This article describes the first large cohort of patients with childhood cancer analysed for the presence of germline pathogenic variants in a panel of cancer predisposition genes.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fletcher, O. & Houlston, R. S. Architecture of inherited susceptibility to common cancer. Nat. Rev. Cancer 10, 353–361 (2010).

Article  CAS  PubMed  Google Scholar 

Subasri, V. et al. Multiple germline events contribute to cancer development in patients with Li–Fraumeni syndrome. Cancer Res. Commun. 3, 738–754 (2023).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Barnett, M. et al. Psychosocial interventions and needs among individuals and families with Li–Fraumeni syndrome: a scoping review. Clin. Genet. 101, 161–182 (2022).

Article  CAS  PubMed  Google Scholar 

Zelley, K. et al. Update on genetic counselor practice and recommendations for pediatric cancer predisposition evaluation and surveillance. Clin. Cancer Res. 30, 3983–3989 (2024).

Article  PubMed  Google Scholar 

Hetherington, K. et al. When genetics and pediatric cancer collide: understanding and optimizing families’ experiences. Neurooncol. Adv. 6, vdae133 (2024).

PubMed  PubMed Central  Google Scholar 

Cavenee, W. K. et al. Genetic origin of mutations predisposing to retinoblastoma. Science 228, 501–503 (1985).

Article  CAS  PubMed  Google Scholar 

Kratz, C. P. et al. Predisposition to cancer in children and adolescents. Lancet Child Adolesc. Health 5, 142–154 (2021).

Article  PubMed  Google Scholar 

Brodeur, G. M., Nichols, K. E., Plon, S. E., Schiffman, J. D. & Malkin, D. Pediatric cancer predisposition and surveillance: an overview, and a tribute to Alfred G. Knudson Jr. Clin. Cancer Res. 23, e1–e5 (2017).

Article  PubMed  PubMed Central  Google Scholar 

Kalish, J. M. et al. Update on surveillance for Wilms tumor and hepatoblastoma in Beckwith–Wiedemann syndrome and other predisposition syndromes. Clin. Cancer Res. https://doi.org/10.1158/1078-0432.CCR-24-2100 (2024).

Kamihara, J. et al. Neuroblastoma predisposition and surveillance — an update from the 2023 AACR Childhood Cancer Predisposition Workshop. Clin. Cancer Res. 30, 3137–3143 (2024).

Article  PubMed  Google Scholar 

MacFarland, S. P. et al. Pediatric cancer screening in hereditary gastrointestinal cancer risk syndromes: an update from the AACR Childhood Cancer Predisposition Working Group. Clin. Cancer Res. 30, 4566–4571 (2024).

Article  PubMed  Google Scholar 

Maese, L. D. et al. Update on recommendations for surveillance for children with predisposition to hematopoietic malignancy. Clin. Cancer Res. 30, 4286–4295 (2024).

Article  PubMed  Google Scholar 

de Andrade, K. C. et al. Genome-first approach of the prevalence and cancer phenotypes of pathogenic or likely pathogenic germline TP53 variants. HGG Adv. 5, 100242 (2024). This article is the first genome-first study to investigate the prevalence and penetrance of pathogenic variants in TP53.

PubMed  Google Scholar 

Custodio, G. et al. Impact of neonatal screening and surveillance for the TP53 R337H mutation on early detection of childhood adrenocortical tumors. J. Clin. Oncol. 31, 2619–2626 (2013).

Article  PubMed  PubMed Central  Google Scholar 

Kratz, C. P. et al. Heterozygous BRCA1 and BRCA2 and mismatch repair gene pathogenic variants in children and adolescents with cancer. J. Natl Cancer Inst. 114, 1523–1532 (2022).

Article  PubMed  Google Scholar 

Levine, A. J. p53: 800 million years of evolution and 40 years of discovery. Nat. Rev. Cancer 20, 471–480 (2020).

Article  CAS  PubMed  Google Scholar 

Malkin, D. et al. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 250, 1233–1238 (1990).

Article  CAS  PubMed  Google Scholar 

Wallace, M. R. et al. Type 1 neurofibromatosis gene: identification of a large transcript disrupted in three NF1 patients. Science 249, 181–186 (1990).

Article  CAS  PubMed  Google Scholar 

Varon, R. et al. Nibrin, a novel DNA double-strand break repair protein, is mutated in Nijmegen breakage syndrome. Cell 93, 467–476 (1998).

Article  CAS  PubMed  Google Scholar 

Heiss, N. S. et al. X-linked dyskeratosis congenita is caused by mutations in a highly conserved gene with putative nucleolar functions. Nat. Genet. 19, 32–38 (1998).

Article  CAS  PubMed  Google Scholar 

Bronner, C. E. et al. Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary non-polyposis colon cancer. Nature 368, 258–261 (1994).

Article  CAS  PubMed  Google Scholar 

Ercan, A. B. et al. Clinical and biological landscape of constitutional mismatch-repair deficiency syndrome: an International Replication Repair Deficiency Consortium cohort study. Lancet Oncol. 25, 668–682 (2024).

Article  CAS  PubMed  Google Scholar 

Fishel, R. et al. The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell 75, 1027–1038 (1993).

Article  CAS  PubMed  Google Scholar 

Miyaki, M. et al. Germline mutation of MSH6 as the cause of hereditary nonpolyposis colorectal cancer. Nat. Genet. 17, 271–272 (1997).

Article  CAS  PubMed  Google Scholar 

Savitsky, K. et al. A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science 268, 1749–1753 (1995).

Article  CAS  PubMed  Google Scholar 

Howlett, N. G. et al. Biallelic inactivation of BRCA2 in Fanconi anemia. Science 297, 606–609 (2002).

Article  CAS  PubMed  Google Scholar 

Vulliamy, T. et al. The RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita. Nature 413, 432–435 (2001).

Article  CAS  PubMed  Google Scholar 

Savage, S. A. et al. TINF2, a component of the shelterin telomere protection complex, is mutated in dyskeratosis congenita. Am. J. Hum. Genet. 82, 501–509 (2008).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Armanios, M. et al. Haploinsufficiency of telomerase reverse transcriptase leads to anticipation in autosomal dominant dyskeratosis congenita. Proc. Natl Acad. Sci. USA 102, 15960–15964 (2005).